SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Alcohol Industry Advises FDA on CBD Regulation

    By

    The Wine & Spirits Wholesalers of America (WSWA) has written a letter to the House and Senate committees in response to a request for information regarding the regulation of CBD and other cannabinoids.

    The response comes five months after it penned a letter to Congress calling for the federal regulation of cannabis.

    According to Marijuana Moment, the letter states that the WSWA believes it is important to insights from the alcohol industry to help inform regulation on cannabis.

    The WSWA suggests that:

    • A specific regulatory category should be created for intoxicating cannabinoids.
    • The Alcohol and Tobacco Tax and Trade Bureau (TTB) should be responsible for such products.

    The letter states: “The transition from Prohibition to legal status for alcohol has been an American success story,” it says. “Since the 21st Amendment’s enactment, a safe, consumer-centric and economically vibrant marketplace has developed, one serving the needs of both regulators and consumers. While individual regulations have evolved, the basic federal regulatory structure of permitting and tax collection continues to endure.

    READ MORE: Cannabis Industry Fees Are Preventing Profits, shows Health Canada Report

    “As Congress considers a potential regulatory pathway for intoxicating hemp products, America’s wine and spirits wholesalers believe it is important to share what our industry has learned over time and to encourage you and other legislators to pursue robust reform and regulation.”

    The call from Congress on feedback on cannabinoid regulations follows an FDA announcement in January 2023 that it would not regulate CBD products. Instead, it would be up to Congress to look at regulating the products.

    The U.S Hemp Roundtable also made a recent reply to the call for feedback, responding on topics such as current market dynamics, THC levels, lack of standards, product definitions, public health impact, product standards and more.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free